phosphoglycerate Mutase 1 (Brain) (PGAM1) (C-Term) Peptide
Quick Overview for phosphoglycerate Mutase 1 (Brain) (PGAM1) (C-Term) Peptide (ABIN2182644)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- EEAIMELNLP TGIPIVYELD KNLKPIKPMQ FLGDEETVRK AMEAVAAQGK
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-PGAM1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PGAM1 (phosphoglycerate Mutase 1 (Brain) (PGAM1))
-
Background
-
Phosphoglyceric acid mutase (EC 2.7.5.3) is widely distributed in mammalian tissues where it catalyzes the reversible reaction of 3-phosphoglycerate (3-PGA) to 2-phosphoglycerate (2-PGA) in the glycolytic pathway.
Alias Symbols: PGAM-B, PGAMA
Protein Size: 254 -
Molecular Weight
- 28 kDa
-
Gene ID
- 5223
-
NCBI Accession
- NM_002629, NP_002620
-
UniProt
- P18669
Target
-